BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15968242)

  • 21. Molecular technology and pancreatic cancer.
    Manu M; Buckels J; Bramhall S
    Br J Surg; 2000 Jul; 87(7):840-53. PubMed ID: 10931017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer.
    Wu H; Chen X; Ji J; Zhou R; Liu J; Ni W; Qu L; Ni H; Ni R; Bao B; Xiao M
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):215-222. PubMed ID: 30793953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications.
    Rodriguez JA; Li M; Yao Q; Chen C; Fisher WE
    World J Surg; 2005 Mar; 29(3):297-305. PubMed ID: 15696394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and immunologic diagnosis of cancer. Pancreatic and gastric cancer.
    Burtin P
    Tumour Biol; 1987; 8(2-3):84-5. PubMed ID: 2452469
    [No Abstract]   [Full Text] [Related]  

  • 25. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
    Duxbury MS; Matros E; Clancy T; Bailey G; Doff M; Zinner MJ; Ashley SW; Maitra A; Redston M; Whang EE
    Ann Surg; 2005 Mar; 241(3):491-6. PubMed ID: 15729073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic cancer: state-of-the-art care.
    Lillemoe KD; Yeo CJ; Cameron JL
    CA Cancer J Clin; 2000; 50(4):241-68. PubMed ID: 10986966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular detection of pancreatic neoplasia: Current status and future promise.
    Majumder S; Chari ST; Ahlquist DA
    World J Gastroenterol; 2015 Oct; 21(40):11387-95. PubMed ID: 26526068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in diagnosis of pancreatic cancer.
    Zhang L; Sanagapalli S; Stoita A
    World J Gastroenterol; 2018 May; 24(19):2047-2060. PubMed ID: 29785074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status and progress of pancreatic cancer in China.
    Lin QJ; Yang F; Jin C; Fu DL
    World J Gastroenterol; 2015 Jul; 21(26):7988-8003. PubMed ID: 26185370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacotherapy for pancreatic cancer: Difficulties and prospects].
    Wang ZH; Zhou J; Shen L
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):712-716. PubMed ID: 28926903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.
    Alhamdani MS; Youns M; Buchholz M; Gress TM; Beckers MC; Maréchal D; Bauer A; Schröder C; Hoheisel JD
    J Proteomics; 2012 Jun; 75(12):3747-59. PubMed ID: 22579748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnosis of "early" pancreatic cancer: the University of Chicago experience.
    Moossa AR; Levin B
    Cancer; 1981 Mar; 47(6 Suppl):1688-97. PubMed ID: 6168357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of pancreatic carcinoma.
    Hunstad DA; Norton JA
    Surg Oncol; 1995; 4(2):61-74. PubMed ID: 7551261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD44 in pancreatic cancer and its significance.
    Li XP; Zhang XW; Zheng LZ; Guo WJ
    Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Etiology and carcinogenesis of pancreatic ductal adenocarcinoma].
    Song SY
    Korean J Gastroenterol; 2008 Feb; 51(2):71-83. PubMed ID: 18349569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Report of Cancer Incidence and Mortality in China, 2014].
    Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic cancer incidence and mortality patterns in china, 2009.
    Chen WQ; Liang D; Zhang SW; Zheng RS; He YT
    Asian Pac J Cancer Prev; 2013; 14(12):7321-4. PubMed ID: 24460295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.
    Osako M; Yonezawa S; Siddiki B; Huang J; Ho JJ; Kim YS; Sato E
    Cancer; 1993 Apr; 71(7):2191-9. PubMed ID: 8384065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic cancer: challenges and opportunities.
    Zhu H; Li T; Du Y; Li M
    BMC Med; 2018 Nov; 16(1):214. PubMed ID: 30463539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.